105,000 Shares in Phibro Animal Health Co. (NASDAQ:PAHC) Purchased by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. acquired a new position in Phibro Animal Health Co. (NASDAQ:PAHC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 105,000 shares of the company’s stock, valued at approximately $2,205,000. Hussman Strategic Advisors Inc. owned approximately 0.26% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also made changes to their positions in the company. Rhumbline Advisers grew its stake in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after purchasing an additional 484 shares during the period. BNP Paribas Financial Markets lifted its position in shares of Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after buying an additional 729 shares in the last quarter. New York State Teachers Retirement System lifted its position in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after buying an additional 775 shares in the last quarter. SG Americas Securities LLC lifted its holdings in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Barclays lifted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, Morgan Stanley lifted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $24.17 on Thursday. The company has a market cap of $978.89 million, a P/E ratio of 50.35, a P/E/G ratio of 0.51 and a beta of 0.52. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The business’s 50 day moving average price is $22.23 and its 200-day moving average price is $22.06. Phibro Animal Health Co. has a fifty-two week low of $11.90 and a fifty-two week high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.99%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.